Comparison of rocuronium‑sugammadex and mivacurium on recovery efficiency after pediatric isolated adenoidectomy: a propensity score‑matched cohort study
In children undergoing isolated adenoidectomy, the rocuronium-sugammadex regimen was associated with modestly shorter extubation time in primary analysis, though this finding was not confirmed in paired sensitivity analysis, together with significantly reduced PACU discharge time and delayed discharge risk, without compromising postoperative recovery safety or comfort.
Abstract
Mivacurium and rocuronium-sugammadex are two commonly used neuromuscular blocking regimens in pediatric otorhinolaryngological surgery. However, existing comparative studies frequently combine isolated adenoidectomy with adenotonsillectomy, introducing significant confounding variables; consequently, dedicated head-to-head comparisons restricted to isolated adenoidectomy remain scarce. This study aimed to compare postoperative recovery efficiency between rocuronium-sugammadex reversal and mivacurium monotherapy, two routinely used clinical regimens, in children aged 3–12 years undergoing isolated adenoidectomy.
Of 877 eligible children, 616 children (308 matched pairs) were analyzed after 1:1 propensity-score matching. The primary endpoint was the time from cessation of anesthetic maintenance agents to tracheal extubation. Secondary endpoints included time from anesthetic cessation to post-anaesthesia care unit (PACU) discharge, emergence quality, and postoperative pain scores.
The median time from anesthetic discontinuation to extubation was 23 min in the rocuronium-sugammadex group versus 25 min in the mivacurium group Hodges-Lehmann (HL) pseudomedian difference − 2 min; (95% CI − 4.00 to − 0.0001;
P
= 0.022). However, this modest between-group difference was not statistically significant in a paired sensitivity analysis (
P
= 0.069). The median interval from drug cessation to PACU discharge was shorter in the rocuronium-sugammadex group (38 [30.00–48.00] min) than in the mivacurium group (42 [34.00–51.00] min), with a HL pseudomedian difference of − 4.00 min (95% CI − 6.00 to − 2.00;
P
< 0.001). Steward scores were comparable (
P
= 0.416); VAS pain scores differed statistically (
P
= 0.016) but the absolute difference was minimal. Subgroup analysis showed that shorter extubation time was observed only in children receiving intraoperative midazolam. Shorter PACU discharge duration was also seen in this subgroup and in both age subgroups, but not in children without midazolam.
In children undergoing isolated adenoidectomy, the rocuronium-sugammadex regimen was associated with modestly shorter extubation time in primary analysis, though this finding was not confirmed in paired sensitivity analysis, together with significantly reduced PACU discharge time and delayed discharge risk, without compromising postoperative recovery safety or comfort. Benefits in extubation time and PACU discharge duration were observed primarily in children receiving intraoperative midazolam; however, formal interaction analysis for this exploratory subgroup comparison did not demonstrate significant effect modification. Taken together, under real-world clinical dosing conditions, these findings suggest that this rocuronium-sugammadex anesthetic strategy may help optimize patient turnover in high-volume pediatric day-surgery centers.
Background
Rocuronium and sugammadex are used cautiously in patients with chronic kidney disease (CKD) undergoing anesthesia because of delayed excretion. This multicenter retrospective study explored the safety and recovery of rocuronium-sugammadex compared to cisatracurium/atracurium-pyridostigmine in patients with C...
D. Lee, S. Oh, H. Kim et al.· Anesthesia and Pain Medicine· 0 citations
Under routine quantitative NMT, sugammadex administration was associated with more frequent achievement of a train-of-four (TOF) ratio ≥0.9 but not with lower incidences of postoperative pneumonia or secondary outcomes.
Soshi Narasaki, Yuki Ota, Hirotsugu Miyoshi et al.· Journal of Anesthesia· 1 citation
Background Children undergoing adenotonsillectomy may be vulnerable to opioid-related adverse effects, creating a need for analgesic strategies that support rapid postoperative recovery. This study compared the perioperative effects of oliceridine and sufentanil in children undergoing adenotonsillectomy under general a...
Yuan Wang, Zhi-Chun Cui, Zhong-Gang Cheng et al.· Drug Design, Development and...· 0 citations
Background/Objectives: Emergence delirium (ED) is common after sevoflurane anesthesia in children undergoing otolaryngologic surgery. Remimazolam is an ultra-short-acting benzodiazepine that may reduce ED without delaying recovery. This study evaluated the effect of a single remimazolam bolus administered at the end of...
Grgur Prižmić, F. Periš, Anamarija Mitar et al.· Biomedicines· 0 citations
Remimazolam-based anesthesia was associated with a lower incidence of PONV compared with sevoflurane in patients undergoing laparoscopic gynecologic oncology surgery, and the observed reduction was slightly smaller than the effect size predefined during sample size estimation.
OBJECTIVES
To compare remimazolam-based with propofol-based anesthesia for induction and maintenance in adult cardiac surgery.
DESIGN
Systematic review and meta-analysis of randomized controlled trials.
SETTING
Cardiovascular centers.
PARTICIPANTS
Adults undergoing cardiac surgery.
INTERVENTIONS
Remimazolam-bas...
Yun-Tai Yao, Shuo Huang, Hong-Bai Wang et al.· Journal of Cardiothoracic an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.